Lotus Pharmaceutical Management
Management criteria checks 1/4
Lotus Pharmaceutical's CEO is Petar Vazharov, appointed in Jan 2018, has a tenure of 6.83 years. directly owns 0.38% of the company’s shares, worth NT$285.50M. The average tenure of the management team and the board of directors is 3.3 years and 1.4 years respectively.
Key information
Petar Vazharov
Chief executive officer
n/a
Total compensation
CEO salary percentage | n/a |
CEO tenure | 6.8yrs |
CEO ownership | 0.4% |
Management average tenure | 3.3yrs |
Board average tenure | 1.4yrs |
Recent management updates
Recent updates
Lotus Pharmaceutical Co., Ltd. (TWSE:1795) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?
Nov 16Lotus Pharmaceutical's (TWSE:1795) Earnings Are Weaker Than They Seem
Nov 14Here's Why Lotus Pharmaceutical (TWSE:1795) Has A Meaningful Debt Burden
Oct 23Lotus Pharmaceutical Co., Ltd. Just Missed Revenue By 5.2%: Here's What Analysts Think Will Happen Next
Aug 14Investors Continue Waiting On Sidelines For Lotus Pharmaceutical Co., Ltd. (TWSE:1795)
Jul 18Is Lotus Pharmaceutical (TWSE:1795) Using Too Much Debt?
Apr 24Benign Growth For Lotus Pharmaceutical Co., Ltd. (TWSE:1795) Underpins Its Share Price
Apr 09Lotus Pharmaceutical's (TWSE:1795) Solid Profits Have Weak Fundamentals
Mar 22These 4 Measures Indicate That Lotus Pharmaceutical (TPE:1795) Is Using Debt Extensively
Apr 04Lotus Pharmaceutical Co., Ltd.'s (TPE:1795) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
Mar 09Did You Miss Lotus Pharmaceutical's (TPE:1795) 64% Share Price Gain?
Feb 11Should You Use Lotus Pharmaceutical's (TPE:1795) Statutory Earnings To Analyse It?
Jan 21Is Lotus Pharmaceutical (TPE:1795) Using Too Much Debt?
Dec 31I Ran A Stock Scan For Earnings Growth And Lotus Pharmaceutical (TPE:1795) Passed With Ease
Dec 10Lotus Pharmaceutical Co., Ltd. Just Missed EPS By 6.5%: Here's What Analysts Think Will Happen Next
Nov 19CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Sep 30 2024 | n/a | n/a | NT$4b |
Jun 30 2024 | n/a | n/a | NT$4b |
Mar 31 2024 | n/a | n/a | NT$4b |
Dec 31 2023 | n/a | n/a | NT$4b |
Sep 30 2023 | n/a | n/a | NT$4b |
Jun 30 2023 | n/a | n/a | NT$5b |
Mar 31 2023 | n/a | n/a | NT$4b |
Dec 31 2022 | n/a | n/a | NT$3b |
Sep 30 2022 | n/a | n/a | NT$3b |
Jun 30 2022 | n/a | n/a | NT$1b |
Mar 31 2022 | n/a | n/a | NT$1b |
Dec 31 2021 | NT$35m | NT$28m | NT$1b |
Sep 30 2021 | n/a | n/a | NT$1b |
Jun 30 2021 | n/a | n/a | NT$1b |
Mar 31 2021 | n/a | n/a | NT$1b |
Dec 31 2020 | NT$18m | NT$14m | NT$1b |
Sep 30 2020 | n/a | n/a | NT$848m |
Jun 30 2020 | n/a | n/a | NT$769m |
Mar 31 2020 | n/a | n/a | NT$519m |
Dec 31 2019 | NT$13m | NT$7m | NT$663m |
Compensation vs Market: Insufficient data to establish whether Petar's total compensation is reasonable compared to companies of similar size in the TW market.
Compensation vs Earnings: Petar's compensation has increased by more than 20% in the past year.
CEO
Petar Vazharov
6.8yrs
Tenure
NT$34,721,000
Compensation
Mr. Petar Antonov Vazharov serves as a Director at Alvogen Korea Co. Ltd. Since March 31, 2021. He is an Executive Vice President of the Asia Pacific Region of Alvogen Group.He is General Manager of Alvog...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO & Director | 6.8yrs | NT$34.72m | 0.38% NT$ 285.5m | |
Chief Financial Officer | 8yrs | NT$5.19m | 0.010% NT$ 7.6m | |
Chief Operations Officer | no data | no data | no data | |
Chief Information Officer | 3.3yrs | no data | 0.0084% NT$ 6.4m | |
Associate Director of Co-Operate Communication | no data | no data | no data | |
Deputy General Manager | no data | no data | 0.0077% NT$ 5.9m | |
Vice President | no data | no data | 0.057% NT$ 42.8m | |
Vice President | no data | no data | 0.011% NT$ 8.6m | |
Chief Commercial Officer-APAC | less than a year | no data | no data | |
Vice President of Research and Development | no data | no data | 0.026% NT$ 20.0m |
3.3yrs
Average Tenure
Experienced Management: 1795's management team is considered experienced (3.3 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO & Director | 10.2yrs | NT$34.72m | 0.38% NT$ 285.5m | |
Chairman | 9.6yrs | NT$959.00k | no data | |
Independent Director | 1.4yrs | no data | no data | |
Director | 2.4yrs | no data | no data | |
Representative Director | less than a year | NT$959.00k | no data | |
Director | 2.4yrs | no data | no data | |
Independent Dierctor | 1.4yrs | no data | no data | |
Representative Director | 1.2yrs | no data | no data | |
Director | 2yrs | no data | no data | |
Independent Director | less than a year | no data | no data | |
Representative Director | less than a year | no data | no data |
1.4yrs
Average Tenure
55yo
Average Age
Experienced Board: 1795's board of directors are not considered experienced ( 1.4 years average tenure), which suggests a new board.